Published in Cancer Sci on November 21, 2016
Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst (2004) 14.97
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med (2015) 13.08
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med (2003) 12.17
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet (2011) 6.77
Total colectomy, mucosal proctectomy, and ileoanal anastomosis. Dis Colon Rectum (1980) 3.77
Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res (1994) 3.25
ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol (2015) 3.19
Hereditary factors in cancer. Study of two large midwestern kindreds. Arch Intern Med (1966) 2.86
The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med (2010) 2.81
Identification of Lynch syndrome among patients with colorectal cancer. JAMA (2012) 2.77
Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut (2008) 2.65
Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. J Clin Oncol (2006) 2.53
Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results. J Clin Oncol (2012) 2.40
Comparison of extended colectomy and limited resection in patients with Lynch syndrome. Dis Colon Rectum (2010) 1.88
Global patterns and trends in colorectal cancer incidence and mortality. Gut (2016) 1.45
Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting. Genet Med (2011) 1.37
Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis. Dis Colon Rectum (1999) 1.29
Meta-analysis of observational studies of ileorectal versus ileal pouch-anal anastomosis for familial adenomatous polyposis. Br J Surg (2006) 1.26
Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol (2014) 1.26
Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited. Fam Cancer (2006) 1.21
Chemoprevention in familial adenomatous polyposis. Best Pract Res Clin Gastroenterol (2011) 1.17
A desmoid tumor-staging system separates patients with intra-abdominal, familial adenomatous polyposis-associated desmoid disease by behavior and prognosis. Dis Colon Rectum (2008) 1.08
Histologic evaluation of prophylactic hysterectomy and oophorectomy in Lynch syndrome. Am J Surg Pathol (2013) 1.05
Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2016) 0.95
Current perspectives on desmoid tumors: the mayo clinic approach. Cancers (Basel) (2011) 0.89
Treatment and follow-up strategies in desmoid tumours: a practice guideline. Curr Oncol (2014) 0.82
Lower prevalence of Lynch syndrome in colorectal cancer patients in a Japanese hospital-based population. Surg Today (2015) 0.82
Quality of life after total proctocolectomy and ileal J-pouch-anal anastomosis. Dis Colon Rectum (1992) 0.80
A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients. BMC Cancer (2015) 0.79
Decision model of segmental compared with total abdominal colectomy for colon cancer in hereditary nonpolyposis colorectal cancer. J Clin Oncol (2010) 0.79
In which patients do I perform IRA, and why? Fam Cancer (2006) 0.78
Feasibility of laparoscopic total proctocolectomy with ileal pouch-anal anastomosis and total colectomy with ileorectal anastomosis for familial adenomatous polyposis: results of a nationwide multicenter study. Int J Clin Oncol (2016) 0.77
Prevalence of laparoscopic surgical treatment and its clinical outcomes in patients with familial adenomatous polyposis in Japan. Int J Clin Oncol (2016) 0.86
Should the Benefit of Adjuvant Chemotherapy in Colon Cancer Be Re-Evaluated? J Clin Oncol (2016) 0.78
Causes of Cancer Death Among First-Degree Relatives in Japanese Families with Lynch Syndrome. Anticancer Res (2016) 0.76
Therapeutic approaches for patients with coexisting familial adenomatous polyposis and colorectal cancer. Jpn J Clin Oncol (2016) 0.75
Impact of venous invasion on the efficacy of adjuvant chemotherapy in elderly patients with stage III colorectal cancer. Med Oncol (2017) 0.75
Current status of local treatment for early rectal cancer in Japan: a questionnaire survey by the 81st Congress of the Japanese Society for Cancer of the Colon and Rectum (JSCCR) in 2014. Int J Clin Oncol (2015) 0.75
Clinical Features of Regorafenib-induced Liver Injury in Japanese Patients From Postmarketing Experience. Clin Colorectal Cancer (2017) 0.75
A randomized controlled trial of surgery and postoperative modified FOLFOX6 versus surgery and perioperative modified FOLFOX6 plus cetuximab in patients with KRAS wild-type resectable colorectal liver metastases: EXPERT study. Langenbecks Arch Surg (2022) 0.75
The role of periodic serum CA19-9 test in surveillance after colorectal cancer surgery. Int J Clin Oncol (2016) 0.75